17-PA
Modify Date: 2025-08-29 11:27:26
17-PA structure
|
Common Name | 17-PA | ||
|---|---|---|---|---|
| CAS Number | 694438-95-4 | Molecular Weight | 430.534 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 599.7±50.0 °C at 760 mmHg | |
| Molecular Formula | C25H34O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 201.8±23.6 °C | |
Use of 17-PA17-PA is a selective antagonist of neurosteroid potentiation and direct gating of GABAA receptors[1]. |
| Name | 17-Phenyl-(3α,5α)-androst-16-en-3-ol |
|---|---|
| Synonym | More Synonyms |
| Description | 17-PA is a selective antagonist of neurosteroid potentiation and direct gating of GABAA receptors[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 599.7±50.0 °C at 760 mmHg |
| Molecular Formula | C25H34O6 |
| Molecular Weight | 430.534 |
| Flash Point | 201.8±23.6 °C |
| Exact Mass | 430.235535 |
| PSA | 20.23000 |
| LogP | 3.14 |
| Vapour Pressure | 0.0±3.9 mmHg at 25°C |
| Index of Refraction | 1.592 |
| Budesonide |
| Respules |
| Spirocort |
| Bidien |
| 2H-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(2-hydroxyacetyl)-4a,6a-dimethyl-8-propyl-, (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)- |
| Budesonide,(11β,16α)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione |
| S-1320 |
| 16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione |
| Budeson |
| Micronyl |
| Pulmicort |
| 17-PA |
| ENTOCORT |
| Rhinocort |
| (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one |
| 2H-naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-, (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)- |
| PREFERID |
| 2-BFI hydrochloride |